Neumora Therapeutics, Inc.'s total assets for Q3 2025 were $177.83M, a decrease of -20.55% from the previous quarter. NMRA total liabilities were $45.67M for the fiscal quarter, a 11.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.